Position in PRGO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$290
-$354 QoQ
Shares Held
28
-53.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#314
of 334 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bruce G. Allen Investments, LLC holds $71,142 across 9 Drug Manufacturers - Specialty & Generic names. PRGO ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
601 | $20,361 | |
| 2 | ZTS |
Zoetis Inc.
|
202 | $14,515 | |
| 3 | HLN |
Haleon plc
|
1,267 | $11,821 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
18 | $9,752 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
448 | $7,181 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
171 | $4,208 | |
| 7 | VTRS |
Viatris Inc
|
120 | $1,905 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
10 | $1,109 |
All Filings in PRGO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290 | 28 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $644 | 60 | Shares | Sole | 2026-05-08 | |
| 2025-03-31 | $140 | 5 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $128 | 5 | Shares | Sole | 2025-01-10 | |
| 2024-06-30 | $0 | 0 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,543 | 79 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $2,542 | 79 | Shares | Sole | 2024-01-11 | |
| No filing history on record for this holder in this stock. | ||||||